Isracann Biosciences Competitors and Similar CompaniesClear all

Isracann Biosciences's competitors and similar companies include Quantum Pharmaceutical, AOP Orphan Pharmaceuticals, Grupo Menarini and Zydus Lifesciences.

	Isracann Biosciences Isracann Biosciences is a pharmaceutical company.	Quantum Pharmaceutical Quantum Pharmaceutical is a manufacturer and supplier of unlicensed medicines and hard-to-source products.	AOP Orphan Pharmaceuticals AOP Orphan is a company focused on clinical development, marketing and distribution of medicines for rare and complex diseases.	Grupo Menarini Grupo Menarini is a pharmaceutical company.	Zydus Lifesciences Zydus Lifesciences (formerly known as Cadila Healthcare) is a company that provides healthcare solutions.
Founding Date	Founding Date 2018	Founding Date 2004	Founding Date 1996	Founding Date 1961	Founding Date 1952
Type	Type Public	Type Subsidiary	Type Private	Type Private	Type Public
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations Vancouver, CA HQ	Locations Hobson, GB HQ	Locations Wien, AT HQ Sofia, BG Meudon, FR Ismaning, DE Athina, GR Budapest, HU see more	Locations Badalona, ES HQ	Locations Ahmedabad, IN HQ Rio De Janeiro, BR Nanterre, FR Ahmedabad, IN Ambernath, IN Ankleshwar, IN Bengaluru, IN see more
Employees	Employees N/A	Employees 4548% increase	Employees 5352% increase	Employees 5541% increase	Employees 27,9176% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £76.1m (FY, 2018)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹267.2b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods £54.5m (FY, 2018)	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹72.9b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit £21.6m (FY, 2018)	Gross profit N/A	Gross profit N/A	Gross profit ₹203.7b (FY, 2026)
Net income	Net income ($4.7m) (FY, 2022)	Net income (£8.3m) (FY, 2018)	Net income N/A	Net income N/A	Net income ₹50.3b (FY, 2026)